| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Chemistry and Biochemistry and the Program in Biochemistry and Molecular Biology, University of California, Santa Barbara, California 93106, USA
1Correspondence: Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA 93106, USA. E-mail: parsons{at}chem.ucsb.edu
Sequence-related vesicular acetylcholine transporter (VAChT) and vesicular monoamine transporter (VMAT) transport neurotransmitter substrates into secretory vesicles. This review seeks to identify shared and differentiated aspects of the transport mechanisms. VAChT and VMAT exchange two protons per substrate molecule with very similar initial velocity kinetics and pH dependencies. However, vesicular gradients of ACh in vivo are much smaller than the driving force for uptake and vesicular gradients of monoamines, suggesting the existence of a regulatory mechanism in ACh storage not found in monoamine storage. The importance of microscopic rather than macroscopic kinetics in structure–function analysis is described. Transporter regions affecting binding or translocation of substrates, inhibitors, and protons have been found with photoaffinity labeling, chimeras, and single-site mutations. VAChT and VMAT exhibit partial structural and mechanistic homology with lactose permease, which belongs to the same sequence-defined superfamily, despite opposite directions of substrate transport. The vesicular transporters translocate the first proton using homologous aspartates in putative transmembrane domain X (ten), but they translocate the second proton using unknown residues that might not be conserved between them. Comparative analysis of the VAChT and VMAT transport mechanisms will aid understanding of regulation in neurotransmitter storage.—Parsons, S. M. Transport mechanisms in acetylcholine and monoamine storage.
Key Words: vesicular acetylcholine transporter • vesicular monoamine transporter • neurotransmitter transport
This article has been cited by other articles:
|
|
 |
|
  K. Sawada, N. Echigo, N. Juge, T. Miyaji, M. Otsuka, H. Omote, A. Yamamoto, and Y. Moriyama From the Cover: Identification of a vesicular nucleotide transporter PNAS, April 15, 2008; 105(15): 5683 - 5686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gopalakrishnan, M. Sievert, and A. E. Ruoho Identification of the Substrate Binding Region of Vesicular Monoamine Transporter-2 (VMAT-2) Using Iodoaminoflisopolol as a Novel Photoprobe Mol. Pharmacol., December 1, 2007; 72(6): 1567 - 1575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Beyenbach and H. Wieczorek The V-type H+ ATPase: molecular structure and function, physiological roles and regulation J. Exp. Biol., February 15, 2006; 209(4): 577 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Anlauf, M. K.-H. Schafer, T. Schwark, N. von Wurmb-Schwark, V. Brand, B. Sipos, H.-P. Horny, R. Parwaresch, W. Hartschuh, L. E. Eiden, et al. Vesicular Monoamine Transporter 2 (VMAT2) Expression in Hematopoietic Cells and in Patients with Systemic Mastocytosis J. Histochem. Cytochem., February 1, 2006; 54(2): 201 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Essand, S Vikman, J Grawe, L Gedda, C Hellberg, K Oberg, T H Totterman, and V Giandomenico Identification and characterization of a novel splicing variant of vesicular monoamine transporter 1 J. Mol. Endocrinol., December 1, 2005; 35(3): 489 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vardy, I. T. Arkin, K. E. Gottschalk, H. R. Kaback, and S. Schuldiner Structural conservation in the major facilitator superfamily as revealed by comparative modeling Protein Sci., July 1, 2004; 13(7): 1832 - 1840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. SIDHU, C. WERSINGER, and P. VERNIER Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse? FASEB J, April 1, 2004; 18(6): 637 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Thevenod Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins Am J Physiol Cell Physiol, September 1, 2002; 283(3): C651 - C672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gunhan, P. V. Choudary, T. E. Landerholm, and L. M. Chalupa Depletion of Cholinergic Amacrine Cells by a Novel Immunotoxin Does Not Perturb the Formation of Segregated On and Off Cone Bipolar Cell Projections J. Neurosci., March 15, 2002; 22(6): 2265 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhu, J. S. Duerr, H. Varoqui, J. R. McManus, J. B. Rand, and J. D. Erickson Analysis of Point Mutants in the Caenorhabditis elegans Vesicular Acetylcholine Transporter Reveals Domains Involved in Substrate Translocation J. Biol. Chem., November 2, 2001; 276(45): 41580 - 41587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. EIDEN The vesicular neurotransmitter transporters: current perspectives and future prospects FASEB J, December 1, 2000; 14(15): 2396 - 2400. [Full Text]
|
|
|
|
|
|
D. S. Thiriot and A. E. Ruoho Mutagenesis and Derivatization of Human Vesicle Monoamine Transporter 2 (VMAT2) Cysteines Identifies Transporter Domains Involved in Tetrabenazine Binding and Substrate Transport J. Biol. Chem., July 13, 2001; 276(29): 27304 - 27315. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
